Skip to content
glp1.howSign in

Talking to your doctor about stopping or tapering off treatment

Thinking about stopping because of cost, side effects, or reaching your goal? Have that conversation with your prescriber on purpose, instead of quietly not refilling.

Updated Sep 26, 2026Evidence-backed

Whether it's cost, side effects, or reaching your goal, stopping a GLP-1 is a decision to make out loud with your prescriber. How you come off the medication shapes a lot of what happens next.

Why this conversation matters

Trial data show most people regain a majority of the weight they lost within a year of stopping. Whether tapering slows that is still being studied (see stopping a GLP-1: tapering, regain, and restarting). If you raise it with your prescriber instead of just letting the prescription lapse, you get a real say in how the transition goes.

Stopping is also common. Across real-world obesity cohorts without diabetes, only about one-third of people are still on therapy at one year (Sisodia, The American Journal of Managed Care, 2026, DOI (external link)). You haven't done anything wrong by wanting to stop, and there's no reason to feel sheepish about bringing it up. Treat it as a planned clinical decision.

Reasons this conversation comes up

  • Cost or insurance coverage changes
  • Side effects that haven't resolved
  • Reaching a personal goal weight and wanting to assess next steps
  • Pregnancy planning, a scheduled surgery, or another health condition
  • Being tired of ongoing injections, or wanting to try life without the medication

Questions to ask

  • "If I stop, what should I realistically expect for my appetite and weight over the following months?"
  • "Is there a tapering approach, or is it all or nothing?" Some prescribers use a reduced maintenance dose instead of a hard stop. Our guide on tapering vs. staying on a maintenance dose long term covers this, and our history of GLP-1 medications discusses dose reduction vs. full discontinuation.
  • "What should I change about my diet or exercise routine going into this transition?"
  • "Should I be doing anything now to protect muscle before I come off?" Weight regained after stopping tends to come back disproportionately as fat, not as the lean mass that was lost, so it's worth getting resistance training and protein intake in place before you stop. See the body-composition section of the stopping guide.
  • "If I decide to restart later, what does that look like?" After a long gap, restarting usually means re-titrating from a low dose, not jumping back to where you left off. Wegovy's label, for example, says to restart the dose escalation at a lower dose after 2 or more missed doses in a row (more on this in our guide to missed doses).

If cost is the reason

Say so. A prescriber who knows cost is driving the decision may have options you haven't considered: a different drug your plan covers or that costs less, manufacturer savings programs, or a structured dose-reduction plan instead of a full stop. Naming the real reason helps your prescriber actually help you.

Study findings above are attributed to their authors and were located via PubMed.

This is peer information, not medical advice. Your clinician knows your full picture — use these prompts to start the conversation, not to replace it.

doctordiscontinuationconversations

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Why shouldn't I just stop refilling my GLP-1 prescription?

    Trial data show most people regain a majority of the weight they lost within a year of stopping, and whether tapering slows that is still being studied. Raising it with your prescriber gives you a real say in how the transition goes, including a plan for appetite, weight, and muscle.

  • What should I ask my doctor before stopping a GLP-1?

    Useful questions from this guide: what to realistically expect for appetite and weight over the following months; whether there's a tapering approach or a reduced maintenance dose instead of a hard stop; what to change about diet or exercise going into the transition; and what restarting would look like if you decide to later.

  • What if I want to stop because I can't afford the medication?

    Say so. A prescriber who knows cost is the reason may have options you haven't considered: a different drug your plan covers or that costs less, manufacturer savings programs, or a structured dose-reduction plan instead of a full stop. Naming the real reason helps your prescriber actually help you.

  • Is stopping GLP-1 treatment a reasonable choice?

    Yes. Stopping is a legitimate decision, whether it's driven by cost, side effects, reaching a personal goal, or wanting to try life without the medication. Make it with your prescriber's input, though, because trial data show substantial regain in the year after stopping, and a planned transition gives you the best chance of managing it.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

3Supporting

2Mixed findings

Revision history

Last updated · 5 revisions recorded.

Show what changed
  1. v5

    Evidence sources 4 → 5

  2. v4

    Common questions revised

  3. v3

    Summary rewritten; Body revised

  4. v2

    Body revised

  5. v1

    Existing article recorded at the start of version history

Improve this page

Community notes

Share helpful experiences and questions. Notes are reviewed before publication and do not replace medical advice.

Loading notes…

    New submissions are currently paused. Existing approved notes remain available.

    Related terms

    • Hazard ratio — A statistic from clinical trials that compares how often an event happens over time in one group versus another; below 1 means a lower rate in the treated group.
    • Sharps container — A puncture-resistant container for safely collecting used needles, pen needles, and syringes until they can be disposed of according to local rules.

    Related guides

    • Stopping a GLP-1: tapering, weight regain, and restarting safely — Whether by choice or circumstance, most people stop a GLP-1 at some point. This guide covers what stopping can and can't get you, what withdrawal trials and real-world data show about weight regain and lost health benefits, whether a GLP-1 is really a medication for life, how tapering compares, and why restarting after a gap usually means re-titrating.
    • Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis — GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.
    • Restarting a GLP-1 after a missed stretch: what each drug's label says about re-titration — Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.
    • Comparing the GLP-1 pills: Ozempic tablets (Rybelsus), the Wegovy pill, and Foundayo — There are now three GLP-1 pills in the US, and they aren't interchangeable: oral semaglutide for diabetes (Rybelsus, now sold as Ozempic tablets), oral semaglutide for weight (the Wegovy pill), and orforglipron (Foundayo). Here's how they compare on approval, how you take them, what the trials found, side effects, cost, and what you give up versus a weekly injection.